Brinsupri 25 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FJG6P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,073
Award facts
- Contract value 100% obligated
- $14,073.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 7, 2026, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), covers the supply of Brintellix (brinsupri) 25 mg tablets in quantities of 30 units, with a ceiling value of $14,073.00 and a completion date of January 29, 2026. The contract employs firm fixed-price pricing and was competitively awarded with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supplies to federal defense and healthcare systems. The company's extensive portfolio includes brand-name and generic medications across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The DLA's Medical Supply Chain relies on this prime vendor relationship to ensure timely delivery of essential pharmaceutical products to military treatment facilities and related federal healthcare institutions globally.
Quick answers
Who was awarded contract SPE2DR26FJG6P?
SPE2DR26FJG6P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FJG6P worth?
The government has obligated $14,073 on SPE2DR26FJG6P.
Is contract SPE2DR26FJG6P an order under another contract?
Yes. SPE2DR26FJG6P is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG6P competed?
The extent of competition for SPE2DR26FJG6P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award